Bivacor's Total Artificial Heart gets FDA Breakthrough Device status, speeding development and possibly transforming heart-failure treatment. Houston Business Journal Select a City ...

BiVacor.com — -- Scientists at the Texas Heart Institute say the perfect bionic heart is within their reach, but it doesn't beat. The average human heart has to beat 42 million times a year ...

BiVACOR's Total Artificial Heart is not your average mechanical heart. It employs the same magnetic levitation technology used in high-speed rail lines, creating a frictionless environment for its ...

The BiVACOR heart could help address this crisis by replacing human heart transplants - perhaps in a decade. More engineering is needed including how to power the device more conveniently.

A 58-year-old in the US has become the first person to survive for several days with a metal heart after his own organ experienced “end-stage” failure. Medical technology company BiVACOR built ...

From world-first breakthroughs in spinal cord repair, artificial heart technology and stroke intervention to Artificial ...

The creation of such a device, today known as the Bivacor Total Artificial Heart, was once inconceivable to almost everyone—but not Bud Frazier. I spoke with Frazier at his office at THI, ...

Australian company BiVACOR has revealed a patient implanted with its artificial heart survived for 100 days – and is still with us after receiving a donated organ.… The un-named man had heart ...

BiVACOR®, a clinical-stage medical device company, today announced $13 million (USD) awarded from the Australian Government’s Medical Research Future Fund (M ...

(Why they called the BiVacor a pump when it doesn’t pump is, I guess, force of habit.) Dr. William Cohn, Dr. Alexis Shafii, Dr. Bud Frazier, and Daniel Timms on July 9.

The BiVACOR THA hooked up with the CTO Dianiel Timms in the background. (Credit: BiVACOR) Outside of the brain, the heart is probably the organ that you miss the most when it ceases to function ...

The grant is matched by in-kind support bringing approximately AUD$2.2 million in funding for BiVACOR’s clinical advancement BiVACOR is an Australian-born innovation, and we are extremely ...